Skip to main content
Signal8

Immunocore Holdings plc (IMCR)

Immunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in its mission to create pioneering immunotherapies. The company's development pipeline addresses a range of serious conditions, including various cancers, infectious diseases, and autoimmune disorders. Its currently marketed product, KIMMTRAK, offers a treatment option for patients with uveal melanoma that is either unresectable or has metastasized. Within oncology, Immunocore is progressing IMC-C103C through early-stage (Phase I/II) dose escalation trials for several solid tumor types, notably non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers. Another key oncology program, IMC-F106C, is also in Phase I/II dose escalation studies for a diverse array of solid malignancies, including NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. For infectious diseases, the company is advancing IMC-I109V in Phase I/II clinical trials for chronic hepatitis B virus, alongside IMC-M113V, which is undergoing preclinical development for human immunodeficiency virus (HIV). Additionally, Immunocore is developing novel therapeutic candidates designed to deliver precise, targeted immunosuppression as a treatment strategy for autoimmune conditions.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

Immunocore Holdings plc logo

Immunocore Holdings plc

NASDAQ:IMCRHealthcare
-2.49%$30.49
AH$30.49+0.00%vs close
Mkt Cap$1.57B
Float44.99M
O/S51.5M
Vol
$ Vol
RVOL
Inst Own101.1%
SI17.3%
Earnings
Dilution
Financials Summary
Revenue$297.57M
Net Income-$26.42M
Total Assets$1.07B
Free Cash Flow-$11.2M
Debt & Equity
Debt 53%
Equity 47%
Total Debt$436.69M
Total Equity$381.03M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in IMCR's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$1.07B
Liabilities$686.24M
Accounts Receivable$73.98M
Accounts Payable$24.36M
Inventory$6.74M
PP&E (Net)$50.24M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDGBPGBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-09-302013-09-30
Revenue$297.57M$247.98M$197.39M$144.23M$27.04M$30.11M$25.67M$23.65M$14.45M$16.46M$11.46M$6.38M$2.04M
YoY Growth20.0%25.6%36.9%433.3%-10.2%17.3%8.5%63.7%-12.2%43.7%79.6%211.9%-
Cost of Revenue$6.21M$5.54M$821K$5.29M$0$74.81M$99.99M$0$0$0$0$0$0
Gross Profit$291.36M$242.44M$196.57M$138.94M$27.04M-$44.7M-$74.32M$23.65M$14.45M$16.46M$11.46M$6.38M$2.04M
Gross Margin97.9%97.8%99.6%96.3%100.0%-148.4%-289.5%100.0%100.0%100.0%100.0%100.0%100.0%
Research and Development$204.47M$177.44M$129.42M$84.31M$74.31M$74.81M$99.99M$83.58M$61.16M$46.01M$22.13M$12.2M$6.54M
Selling, General, and Administrative$120.62M$121.17M$114.35M$0$82.15M$45.74M$44.18M$34.16M$22.03M$3.75M$2.99M$2.47M$1.17M
Other$0$152K$0$97.4M$0-$79.05M-$100.18M$0-$310K-$824K$0-$989K-$867K
Total Operating Expenses$325.09M$298.77M$243.77M$181.71M$156.46M$41.5M$44M$117.73M$82.87M$48.94M$25.11M$13.69M$6.84M
Operating Income (EBIT)-$33.74M-$56.28M-$47.2M-$42.77M-$129.42M-$86.19M-$118.32M-$93.45M-$67.53M-$32.48M-$13.65M-$7.31M-$4.79M
Operating Margin-11.3%-22.7%-23.9%-29.7%-478.5%-286.2%-460.9%-395.1%-467.4%-197.3%-119.2%-114.6%-234.3%
Interest Expense$12.17M$18.84M$4.08M$5.41M$5.57M$3.11M$3.8M$842K$0$0$0$0$0
Interest Income$16.48M$25.62M$14.23M$3.76M$65K$706K$1.4M$822K$0$0$0$0$26K
Other Income (Expense)$19.53M$14.01M-$982K$8.95M-$3.92M-$1.17M$36.65M$5.28M$2.79M$1.27M$28.07M$122K$26K
Income Before Tax (EBT)-$14.21M-$42.32M-$48.19M-$33.82M-$133.34M-$87.36M-$81.67M-$88.18M-$64.73M-$31.21M$14.41M-$7.19M-$4.77M
Income Tax Expense$12.21M-$1.48M-$4.43M$9.65M$111K-$13.27M$22.26M-$16.55M$15.81M$8.08M$960K$1.59M$1.07M
Net Income-$26.42M-$40.81M-$43.75M-$43.46M-$133.45M-$74.09M-$103.93M-$71.63M-$49.57M-$23.13M$13.45M-$5.59M-$3.69M
Net Income Margin-8.9%-16.5%-22.2%-30.1%-493.4%-246.0%-404.9%-302.8%-343.1%-140.5%117.4%-87.7%-180.6%
Supplementary Data
EPS-0.53-1.02-0.89-0.95-3.13-2.33-3.81-2.62-20.16-9.450.00-2.530.00
Diluted EPS-0.53-1.02-0.89-0.95-3.00-2.33-3.81-2.62-20.16-9.450.00-2.530.00
Weighted Average OS50.35M49.99M48.89M45.71M42.49M31.78M27.31M27.31M2.46M2.45M02.21M0
EBITDA$387K-$37.66M-$40.87M-$38.37M-$123.71M-$79.59M-$108.96M-$86.75M-$64.33M-$29.7M-$11.16M-$6.6M-$4.36M
EBITDA Margin0.1%-15.2%-20.7%-26.6%-457.4%-264.3%-424.5%-366.7%-445.3%-180.4%-97.4%-103.4%-213.2%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDGBPGBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-09-302013-09-30
Assets
Current Assets
Cash and Cash Equivalents$467.71M$455.73M$350.27M$402.47M$321.06M$176.78M$97.99M$124.39M$83.99M$134.29M$219.98M$50.84M$16.32M
Short-Term Investments$396.44M$364.64M$0$0$0$0$0$0$34.55M$42.22M$0$0$0
Cash and Short-Term Investments$864.15M$820.38M$350.27M$402.47M$321.06M$176.78M$97.99M$124.39M$118.54M$176.51M$219.98M$50.84M$16.32M
Accounts Receivable$73.98M$83.1M$48.62M$57.08M$33.52M$2.05M$66.3M$4.37M$4K$430K$186K$203K$307K
Inventory$6.74M$5.45M$3.56M$692K$0-$6.51M$0-$7.57M$0$0$0$0$0
Other Current Assets$51.87M$7.9M$7.68M$3.62M-$7.69M-$25.9M$352K$42.42M$18.14M$10.6M$6.55M$2.35M$1.41M
Total Current Assets$996.74M$929.86M$418.48M$473.98M$354.58M$152.93M$164.64M$171.18M$145.37M$191.09M$228.96M$54.24M$18.04M
Long-Term Assets
Property, Plant & Equipment Net$50.24M$47.73M$33.82M$38.78M$42.56M$36.85M$72.7M$20.87M$24.24M$11.06M$7.81M$2.65M$1.29M
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$410$0$0$0$318K$743K$372K$142K$207K$258K
Long-Term Investments$0$0$0$137K$223K$973K$0$0$0$14.76M$36.62M$3.78M$65
Deferred Tax Assets$0$14.79M$8.68M$5.12M$3.48M$2.23M$2M$872K$0$0$0$0$0
Other Long-Term Assets$20.28M$17.12M$11.45M$8.75M$6.44M$4.21M$6.6M$2.53M$27.69M$1.8M$0$0$0
Total Long-Term Assets$70.53M$79.64M$53.96M$52.78M$52.7M$44.26M$81.3M$24.6M$52.67M$27.99M$44.57M$6.63M$1.54M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$1.07B$1.01B$472.44M$526.76M$407.28M$197.19M$245.94M$195.78M$198.04M$219.08M$273.53M$60.87M$19.58M
Liabilities
Current Liabilities
Accounts Payable$24.36M$25.1M$14.08M$14.45M$10.12M$7.88M$20.84M$6.44M$8.15M$3.11M$3.62M$825K$566K
Short-Term Debt$0$0$0$0$0$9.84M$27.96M$0$0$0$0$0$0
Current Income Tax Payable$0$0$1.43M$1.12M$718K$620K$95K$779K$0$0$0$0$0
Current Unearned Revenue$583K$0$0$7.76M$33M$27.12M$37.78M$0$0$0$0$0$0
Other Current Liabilities$16.54M$13.1M$9.18M$9.15M$84K-$19.8M$25.28M$29.91M$15.66M$13.46M$299K$158K$8.44M
Total Current Liabilities$246.7M$212.18M$110.01M$100.83M$82.57M$55M$111.96M$49.61M$30.15M$21.8M$22.63M$18.6M$8.44M
Long-Term Liabilities
Long-Term Debt$393.13M$391.01M$37.99M$47.81M$50.24M$36.65M$0$18.88M$17.17M$0$0$0$0
Long-Term Unearned Revenue$4.86M$5.43M$4.36M$5.24M$8.65M$24.87M$63.54M$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0-$24.87M$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$774K$2.21M$77K$25.01M$139K$70.71M$13.17M$22.29M$36.41M$44.37M$0
Total Long-Term Liabilities$439.54M$436.61M$70.54M$87.02M$93.19M$86.85M$114.41M$89.59M$30.34M$22.29M$36.41M$44.37M$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$686.24M$648.79M$180.55M$187.86M$175.76M$141.85M$226.37M$139.19M$60.49M$44.1M$59.04M$62.98M$8.44M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0
Common Stock$136K$135K$83K$129K$119K$64K$0$0$0$0$0$2K$2K
Retained Earnings-$831.27M-$795.76M-$589.3M-$689.39M-$649.7M-$349.87M-$369.75M-$175.18M-$111.48M-$61.07M-$11M-$27.77M-$22.2M
Comprehensive Income & Other-$28.08M-$33.76M-$28.7M-$54.67M$521.31M$405.15M$14.08M$67K$22.06M$12.72M$1.9M$69K$0
Other Stockholders' Equity$1.21B$1.16B$881.1M$1.03B$881.11M$405.15M$389.31M$231.76M$249.03M$236.06M$225.49M$25.66M$25.2M
Total Equity$381.03M$360.72M$291.89M$338.9M$231.53M$55.35M$19.57M$56.58M$137.55M$174.98M$214.5M-$2.1M$3M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$1.07B$1.01B$472.44M$526.76M$407.28M$197.19M$245.94M$195.78M$198.04M$219.08M$273.53M$60.87M$11.44M
Supplementary Data
Total Debt$436.69M$432.72M$66.5M$81.45M$86.16M$74.47M$78.7M$18.88M$17.17M$0$0$0$0
Net Debt-$31.02M-$23.01M-$283.77M-$321.02M-$234.9M-$102.31M-$19.29M-$105.51M-$66.82M-$134.29M-$219.98M-$50.84M-$16.32M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
CurrencyUSDUSDGBPGBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-09-302013-09-30
Operating Activities
Net Income-$26.42M-$51.09M-$34.32M-$52.54M-$180.03M-$74.09M-$103.93M-$71.63M-$49.57M-$23.13M$13.45M-$5.59M-$3.69M
Depreciation & Amortization$2.43M$4.2M$3.24M$4.39M$5.5M$9.23M$9.36M$6.71M$4.1M$2.78M$1.36M$714K$432K
Deferred Income Tax$11M$0$0-$3.53M-$12.69M-$13.27M-$22.26M-$16.55M$0$0$0$0$0
Stock-Based Compensation$0$34.19M$25.69M$32.89M$48.89M$8.16M$3.06M$666K$3.26M$1.68M$1.48M$65K$4K
Changes in Working Capital:
  Accounts Receivable-$5.46M-$12.35M-$14.14M-$26.26M-$4.86M-$532K$1.83M$0-$6.5M-$1.69M-$1.69M-$1.15M-$58K
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable-$1.83M$7.27M$2.08M$4.91M$1.47M$0$0$0$0$0$0$0$0
  Other Working Capital$366K$50.2M$16.64M-$2.81M-$18.57M-$28.27M-$11.92M$67.58M-$10.15M-$1.8M$0$0$0
Total Working Capital Change-$6.92M$45.13M$4.58M-$24.16M-$21.96M-$28.8M-$10.09M$67.58M-$16.65M-$3.49M-$1.69M-$1.15M-$58K
Other Non-Cash Items$11.94M-$6.38M$3.14M-$6.25M$17.19M$38.19M$22.49M-$3.4M-$2.87M-$14.74M-$32.52M$45.76M$14.58M
Net Cash from Operating-$7.97M$26.06M$2.33M-$49.21M-$143.11M-$60.57M-$101.38M-$16.63M-$61.73M-$36.9M-$17.92M$39.79M$11.26M
Investing Activities
Capital Expenditures-$3.23M-$5.17M-$3.37M-$2.2M-$1.39M-$3.07M-$4.28M-$3.54M-$17.73M-$6.18M-$5.79M-$2.03M-$579K
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments-$22.32M-$350M$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$13.39M$0$0$0$0$0$0$27.45M$0$0$0$0$0
Other Investing Activities$0$44K-$925K$6K$106K$3.54M$139K$34.1M$7.99M$35.6M$596K-$3.65M$104K
Net Cash from Investing-$12.16M-$355.13M-$4.29M-$2.2M-$1.28M$467K-$4.14M$58.01M-$9.74M$29.42M-$5.2M-$5.68M-$475K
Financing Activities
Debt Repaid--$352.5M----$45.13M$4.04M--$18.77M----
Common Stock Issuance$9.2M$6.8M$0$139.51M$286.89M$113.41M$59.87M$0$0$0$0$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0-$15.42M$27.18M$5.93M$1.3M-$42.6M-$711K$101K$561K$96K$158.36M$404K$3M
Net Cash from Financing$9.2M$343.88M$27.18M$145.44M$288.19M$115.94M$55.13M$101K$19.33M$96K$158.36M$404K$3M
Forex Effect$19.81M-$1.71M$6.56M-$12.65M$625K-$84K-$33K$13K-$10K$11K$0$0$207K
Net Change in Cash$8.89M$13.11M$31.78M$81.39M$144.42M$55.75M-$50.42M$41.5M-$52.15M$134.29M$0$50.84M$16.32M
Supplementary Data
Operating Cash Flow-$7.97M$26.06M$2.33M-$49.21M-$143.11M-$60.57M-$101.38M-$16.63M-$61.73M-$36.9M-$17.92M$39.79M$11.26M
Capital Expenditure-$3.23M-$5.17M-$4.29M-$2.2M-$1.39M-$3.07M-$4.28M-$3.54M-$17.73M-$6.18M-$5.79M-$2.03M-$579K
Free Cash Flow-$11.2M$20.89M-$1.97M-$51.41M-$144.49M-$63.65M-$105.65M-$20.16M-$79.46M-$43.08M-$23.71M$37.76M$10.69M
Cash at Beginning$338.23M$442.63M$318.5M$321.08M$176.66M$73.97M$124.39M$82.88M$136.14M$0$0$0$0
Cash at End$347.11M$455.73M$350.27M$402.47M$321.08M$129.72M$73.97M$124.39M$83.99M$134.29M$0$50.84M$16.32M